Regulating clinical trials in Europe
Ces deux articles analysent la controverse suscitée par une directive de l'Union Européenne sur la réglementation des essais cliniques
Many medical researchers seem to agree that the European legislation on clinical trials needs to change. Between 2007 and 2011, the number of clinical trials started in Europe fell by 25%. Much criticism has been directed towards the European Union's (EU) Clinical Trials Directive, which is widely believed to have led to an increase in unnecessary bureaucracy.
The aims of the Directive were admirable. Harmonisation of the rules across the EU would allow cross-border trials, while minimum standard ...
The Lancet Oncology , commentaire, 2012